Showing results (151-160 of 240) with videos related to

Sort By:
Pageof 24
Leukemia & Lymphoma|September 15, 2021
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI)Paola Guglielmelli, Francesca Palandri, Carmine Selleri, et al.
Plos One|December 15, 2010
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosisVittorio Rosti, Elisa Bonetti, Gaetano Bergamaschi, et al.
Blood|November 16, 2002
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemiaAlois Gratwohl, Ronald Brand, Jane Apperley, et al.
Haematologica|April 30, 2008
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapyDaniela Cilloni, Francesca Messa, Francesca Arruga, et al.
Blood|October 18, 2002
Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)Loïc Fouillard, Myriam Labopin, Norbert-Claude Gorin, et al.
Haematologica|May 13, 2008
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remissionLoic Fouillard, Myriam Labopin, Alois Gratwohl, et al.
Cancers|March 6, 2021
The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid LeukemiaValentina Gaidano, Mohammad Houshmand, Nicoletta Vitale, et al.
Cancer|January 31, 2006
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cellsAlessandro Morotti, Daniela Cilloni, Francesca Messa, et al.
Cell Death & Disease|June 2, 2017
Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemiaLuciana De Luca, Stefania Trino, Ilaria Laurenzana, et al.
Stem Cells (Dayton, Ohio)|November 29, 2008
Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectinGianmario Sambuceti, Silvia Morbelli, Luca Vanella, et al.
Pageof 24